These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31156346)
1. Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis. Wang W; Huang CY; Wang ZP; Xu SS; Qian TY; Chen YD; Wu WG J Med Biochem; 2019 Jul; 38(3):353-360. PubMed ID: 31156346 [TBL] [Abstract][Full Text] [Related]
2. Serum CX3CL1/fractalkine concentrations are positively associated with disease severity in postmenopausal osteoporotic patients. Chen YD; Huang CY; Liu HY; Yao WF; Wu WG; Lu YL; Wang W Br J Biomed Sci; 2016 Jul; 73(3):121-128. PubMed ID: 27476376 [TBL] [Abstract][Full Text] [Related]
3. Correlation of Serum CCL3/MIP-1α Levels with Disease Severity in Postmenopausal Osteoporotic Females. Wan H; Qian TY; Hu XJ; Huang CY; Yao WF Balkan Med J; 2018 Jul; 35(4):320-325. PubMed ID: 29666038 [TBL] [Abstract][Full Text] [Related]
4. Elevated CCL2/MCP-1 Levels are Related to Disease Severity in Postmenopausal Osteoporotic Patients. Yang XW; Wang XS; Cheng FB; Wang F; Wan L; Wang F; Huang HX Clin Lab; 2016 Nov; 62(11):2173-2181. PubMed ID: 28164676 [TBL] [Abstract][Full Text] [Related]
5. The Neuropeptide Vasoactive Intestinal Peptide Levels in Serum are Inversely Related to Disease Severity of Postmenopausal Osteoporosis: A Cross-Sectional Study. Wang W; Wang ZP; Huang CY; Chen YD; Yao WF; Shi BM Genet Test Mol Biomarkers; 2019 Jul; 23(7):480-486. PubMed ID: 31157986 [No Abstract] [Full Text] [Related]
6. Involvement of Eotaxins (CCL11, CCL24, CCL26) in Pathogenesis of Osteopenia and Osteoporosis. Ahmadi H; Khorramdelazad H; Hassanshahi G; Abbasi Fard M; Ahmadi Z; Noroozi Karimabad M; Mollahosseini M Iran J Public Health; 2020 Sep; 49(9):1769-1775. PubMed ID: 33643953 [TBL] [Abstract][Full Text] [Related]
7. Decreased Serum Maresin 1 Concentration Is Associated With Postmenopausal Osteoporosis: A Cross-Sectional Study. Wu J; Li XY; Fang X; Teng FY; Xu Y Front Med (Lausanne); 2021; 8():759825. PubMed ID: 35083231 [No Abstract] [Full Text] [Related]
8. Elevated serum CCL4/MIP-1β levels in postmenopausal osteoporosis patients are linked with disease severity. Yang XW; Wang F; Qin RZ; Zhou QL; Huang HX Biomark Med; 2019 Jan; 13(1):17-25. PubMed ID: 30561228 [TBL] [Abstract][Full Text] [Related]
9. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study. Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496 [TBL] [Abstract][Full Text] [Related]
10. Plasma LncRNA MALAT1 Expressions Are Negatively Associated with Disease Severity of Postmenopausal Osteoporosis. Qian TY; Wan H; Huang CY; Hu XJ; Yao WF Lab Med; 2022 Sep; 53(5):446-452. PubMed ID: 35311990 [TBL] [Abstract][Full Text] [Related]
11. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China. Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait. Al-Shoumer KA; Nair V Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292 [TBL] [Abstract][Full Text] [Related]
13. Serum CTRP3 concentrations are positively correlated with disease severity in women with postmenopausal osteoporosis: a population-based cross-sectional study. Zhang XJ; Zhang D; Qin J; Zhou YR; Guo JL; Zhang YZ Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):10868-10874. PubMed ID: 38039016 [TBL] [Abstract][Full Text] [Related]
14. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women. Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696 [TBL] [Abstract][Full Text] [Related]
15. Serum chitotriosidase in postmenopausal women with severe osteoporosis. Musumeci M; Palermo A; D'Onofrio L; Vadalà G; Greto V; Di Stasio E; Maddaloni E; Di Rosa M; Tibullo D; Angeletti S; Napoli N; Denaro V; Manfrini S Osteoporos Int; 2016 Feb; 27(2):711-6. PubMed ID: 26243359 [TBL] [Abstract][Full Text] [Related]
16. Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females. Lateef M; Baig M; Azhar A Osteoporos Int; 2010 May; 21(5):751-5. PubMed ID: 19597912 [TBL] [Abstract][Full Text] [Related]
17. The Role of Serum Expression Levels of Microrna-21 on Bone Mineral Density in Hypostrogenic Postmenopausal Women with Osteoporosis: Study on Level of RANKL, OPG, TGFβ-1, Sclerostin, RANKL/OPG Ratio, and Physical Activity. Suarjana IN; Isbagio H; Soewondo P; Rachman IA; Sadikin M; Prihartono J; Malik SG; Soeroso J Acta Med Indones; 2019 Jul; 51(3):245-252. PubMed ID: 31699948 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Garnero P; Borel O; Delmas PD Clin Chem; 2001 Apr; 47(4):694-702. PubMed ID: 11274020 [TBL] [Abstract][Full Text] [Related]
19. [Relationship of iron overload to bone mass density and bone turnover in postmenopausal women with fragility fractures of the hip]. Zhang LL; Jiang XF; Ai HZ; Jin ZD; Xu JX; Wang B; Xu W; Xie ZG; Zhou HB; Dong QR; Xu YJ Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):518-21. PubMed ID: 24091266 [TBL] [Abstract][Full Text] [Related]
20. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Han W; Bai X; Wang N; Han L; Sun X; Chen X Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]